Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
Clinical trial NCT00701714 · TERMINATED
Trial details
- NCT number
- NCT00701714
- Sponsor
- Sandoz
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-07-01
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.